These in vivo data are in line with what we report in this paper, in fact we suggest the possibility in the APS of a role of anti-β2-GPI antibodies in the activation of the thrombotic cascade via the HMGB1 platelet pathway. This evidence concerns the gene APOH and autoimmune polyendocrinopathy.